ARCHIVES

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

House Appropriations by Institute

July 8, 1994

ASCO Special Awards Honor Oncology Leaders.

April 2, 2010

Funding Opportunities

October 25, 2002

House panel gives NIH 0.5 percent increase, matching the President’s budget request.

June 17, 2005

In Brief: NCI Grants Get More Money, Pay Line Boosted To 193

May 22, 1981

Eppley Probe Could Lead to Tighter Reporting By NIH supported Investigators

June 17, 1977